SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-17-018899
Filing Date
2017-11-09
Accepted
2017-11-09 16:16:57
Documents
61
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q acrx20170930_10q.htm 10-Q 1152768
2 EXHIBIT 10.1 ex_98728.htm EX-10.1 174593
3 EXHIBIT 31.1 ex_98729.htm EX-31.1 9769
4 EXHIBIT 31.2 ex_98730.htm EX-31.2 9712
5 EXHIBIT 32.1 ex_98731.htm EX-32.1 7605
  Complete submission text file 0001437749-17-018899.txt   4857912

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT acrx-20170930.xml EX-101.INS 881408
7 XBRL TAXONOMY EXTENSION SCHEMA acrx-20170930.xsd EX-101.SCH 55099
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20170930_cal.xml EX-101.CAL 32799
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20170930_def.xml EX-101.DEF 319684
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20170930_lab.xml EX-101.LAB 269371
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20170930_pre.xml EX-101.PRE 334471
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 171191040
SIC: 2834 Pharmaceutical Preparations